Results 141 to 150 of about 4,412 (151)

Real-World Effectiveness of COVID-19 Vaccines (ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2) in Jakarta: Protocol for Test-Negative Design of Health Care Data.

JMIR Res Protoc
Burhan E, Azzumar F, Sinuraya FAG, Rakasiwi MID, Akbar I, Mubarak F, Rengganis AT, Rachmadi RA, Afidjati H.   +8 more
europepmc   +1 more source

Effectiveness of Sinopharm’s BBIBP-CorV Booster Vaccination Against COVID-19-Related Severe and Critical Cases and death in Morocco During the Omicron Wave

, 2023
Belayachi J, Mhayi A, Majidi H, Fahime EE, Abouqal R.   +4 more
europepmc   +1 more source

New diagnosis of multiple sclerosis in the setting of recent Sinopharm COVID-19 vaccine (BBIBP-CorV) exposure: A series of clinical cases and updated review of the literature. [PDF]

Curr J Neurol
Paybast S, Jameie M, Shahbazi M, Habibi MA, Mohammadianinejad SE, Harirchian MH.   +5 more
europepmc   +1 more source

Antibody and transcription landscape in peripheral blood mononuclear cells of elderly adults over 70 years of age with third dose of COVID-19 BBIBP-CorV and ZF2001 booster vaccine. [PDF]

Immun Ageing
Zhang Y, Zhao L, Zhang J, Zhang X, Han S, Sun Q, Yao M, Pang B, Duan Q, Jiang X.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bbibp-corv

Reactions Weekly, 2023
  +21 more sources